The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksUpdated•Originally published 7 May 2026•Updated 9 May 2026•

1 min read

Ispire Technology and ImmunityBio Post Wider-than-Expected Quarterly Losses

Key Facts

1Ispire Technology reported a quarterly loss of $0.17 per share, significantly wider than the Zacks Consensus Estimate of a $0.02 loss.

2ImmunityBio reported a quarterly loss of $0.09 per share compared to the Zacks Consensus Estimate of a $0.08 loss.

Small-cap firms Ispire Technology and ImmunityBio reported quarterly financial results that missed earnings per share (EPS) estimates. Ispire Technology reported a loss of $0.17 per share, significantly wider than the Zacks Consensus Estimate of a $0.02 loss. Similarly, ImmunityBio posted a quarterly loss of $0.09 per share, slightly exceeding the anticipated loss of $0.08. Joining the trend of underperformance, Airship AI Holdings (AISP) reported a loss of $0.04 per share, wider than the estimated $0.01 loss. While some firms showed year-over-year improvements in loss margins, the consistent misses remain a primary concern for investors. These results are expected to trigger short-term selling pressure across the small-cap sector. Analysts are now focusing on the companies' trajectories toward narrowing these deficits in future periods.

26 days ago

Version History

Version 126 days ago

What changed: Added Q1 earnings results for Airship AI Holdings (AISP), noting an earnings per share miss compared to analyst estimates.